0001140361-14-021504.txt : 20140515 0001140361-14-021504.hdr.sgml : 20140515 20140515152541 ACCESSION NUMBER: 0001140361-14-021504 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140515 EFFECTIVENESS DATE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ridgeback Capital Investments L.P. CENTRAL INDEX KEY: 0001423994 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12856 FILM NUMBER: 14846668 BUSINESS ADDRESS: STREET 1: 75 NINTH AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 212-808-7729 MAIL ADDRESS: STREET 1: 75 NINTH AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001423994 XXXXXXXX 12-31-2012 12-31-2012 Ridgeback Capital Investments L.P.
75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
13F HOLDINGS REPORT 028-12856 Y Ridgeback Capital Investments Ltd. is the general partner of Ridgeback Capital Investments L.P. Pursuant to an investment management agreement, Ridgeback Capital Management LP maintains investment and voting power with respect to the securities held or controlled by Ridgeback Capital Investments Ltd. Wayne Holman, an individual, controls Ridgeback Capital Management LP. Ridgeback Capital Management LP, Ridgeback Capital Investments Ltd. and Wayne Holman do not own any securities reported herein directly.
Ridgeback Capital Investments Ltd., as General Partner, by Bud Holman Director 212-808-7729 /s/ Bud Holman New York NY 05-15-2014 2 2 34220 true 1 0001357610 028-12280 Ridgeback Capital Management LP 2 0001358916 028-12277 Ridgeback Capital Investments Ltd.
INFORMATION TABLE 2 form13fInfoTable.xml CELLDEX THERAPEUTICS INC Common Stock 15117B103 25529 3804646 SH SOLE 1,2 0 0 3804646 IRONWOOD PHARMACEUTICALS INC Common Stock 46333X108 8691 784381 SH SOLE 1,2 0 0 784381